NeuroInDx’s FAST-MD concept is selected for the NIH SBIR Niche Assessment Program (NOT-OD-08-100). Foresight Science and Technology will perform Technology Niche Analyses (TNA™) to assess potential uses of FAST-MD technology and its advantages, competitors, market, price and a commercialization strategy.
-
Recent News
- NeuroInDx completes NIH SBIR Commercialization Assistance Program
- 232
- NeuroInDx receives fourth NIH/NIMH SBIR Phase I award
- NIH SBIR Commercialization Assistance Program
- Society for Neuroscience’s 40th Annual Meeting – San Diego
- American Neurological Association’s 135th Annual Meeting in San Francisco, CA
- NeuroInDx’s FAST-MD concept
- NeuroInDx receives NIH/NCRR SBIR Phase II award
- Experimental Biology
- Epilepsy Pipeline Update